F325-1303 Screening compound: 1-(morpholin-4-yl)-4-{5-[(4-propylpiperazin-1-yl)sulfonyl]-2,3-dihydro-1H-indol-1-yl}butane-1,4-dione

F325-1303 Screening compound: 1-(morpholin-4-yl)-4-{5-[(4-propylpiperazin-1-yl)sulfonyl]-2,3-dihydro-1H-indol-1-yl}butane-1,4-dione
F325-1303 Screening compound: 1-(morpholin-4-yl)-4-{5-[(4-propylpiperazin-1-yl)sulfonyl]-2,3-dihydro-1H-indol-1-yl}butane-1,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound F325-1303
1-(morpholin-4-yl)-4-{5-[(4-propylpiperazin-1-yl)sulfonyl]-2,3-dihydro-1H-indol-1-yl}butane-1,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F325-1303

Molecular Formula

C23H34N4O5S (C23 H34 N4 O5 S)

Compound Name

1-(morpholin-4-yl)-4-{5-[(4-propylpiperazin-1-yl)sulfonyl]-2,3-dihydro-1H-indol-1-yl}butane-1,4-dione

IUPAC name

1-(morpholin-4-yl)-4-{5-[(4-propylpiperazin-1-yl)sulfonyl]-23-dihydro-1H-indol-1-yl}butane-14-dione

SMILES

CCCN(CC1)CCN1S(c(cc1)cc(CC2)c1N2C(CCC(N1CCOCC1)=O)=O)(=O)=O

InChI

InChI=1S/C23H34N4O5S/c1-2-8-24-10-12-26(13-11-24)33(30,31)20-3-4-21-19(18-20)7-9-27(21)23(29)6-5-22(28)25-14-16-32-17-15-25/h3-4,18H,2,5-17H2,1H3

InChI Key

CZOFAWODRYCAMA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27116757

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

478.61

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.777

Distribution Coefficient, logD

0.687

Water Solubility, LogSw

-2.27

Polar Surface Area

75.192

Acid Dissociation Constant (pKa)

22.18

Base Dissociation Constant (pKb)

6.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

65.20

F325-1303 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F325-1303 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F325-1303?
Check Price and Availability of F325-1303, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F325-1303 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F325-1303
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F325-1303
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F325-1303 available by request